AnthonyJamesJapourMD

Infectious Disease • Miami, FL

Physician

Join to view full profile

Dr. Japour is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Japour's full profile

Already have an account?

Office
650 NE 32nd St
#2301
Miami, FL 33137

Education & Training

Mount Auburn HospitalResidency, Internal Medicine, 1986 - 1989
Northwestern University The Feinberg School of MedicineClass of 1986

Certifications & Licensure

FL State Medical License 2003 - 2026
MA State Medical License 1987 - 2007
IL State Medical License 1997 - 2002
American Board of Internal Medicine Internal Medicine

Clinical Trials

A Phase I Open-Label Study of the Safety, Tolerance, and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive Individuals
Completed
Phase 1

Publications & Presentations

PubMed

72 citations
HIV-1 genotypic zidovudine drug resistance and the risk of maternal-infant transmission in the women and infants transmission study.
Seth L. Welles, Jane Pitt, Robert C. Colgrove, Kenneth McIntosh, Pei Hua Chung
AIDS. 2000-02-18
79 citations
Selective vertical transmission of HIV-1 antiretroviral resistance mutations
Robert C. Colgrove, Jane Pitt, Pei Hua Chung, Seth L. Welles, Anthony J. Japour
AIDS. 1998-12-03
525 citations
Lopinavir–Ritonavir versus Nelfinavir for the Initial Treatment of HIV Infection
Sharon Walmsley, Barry Bernstein, Martin T. King, Jose R. Arribas, Gildon N. Beall
The New England Journal of Medicine. 2002-06-27

Press Mentions

Diabetes Research Institute Announces Breakthrough Transplantation Approach for the Treatment of Type 1 Diabetes at ADA 2024June 21st, 2024
Preclinical Study Demonstrates Long-Term Success of Allogeneic Islet Implantation for DiabetesMay 17th, 2022
iTolerance, Inc. Announces Formation of Scientific Advisory Board with Appointment of International Leaders in Immune Tolerance DiscoveriesSeptember 13th, 2021

Grant Support

ZDV Resistance In Maternal/Infant HIV-1 TransmissionNational Institute Of Allergy And Infectious Diseases1995–1997
Drug Resistant HIV-1 Rt--Molecular Structure &FunctionNational Institute Of Allergy And Infectious Diseases1992–1995